David Bauché Merck & Co., Inc., MRL, South San Francisco, USA, USA,
1 protocol

Daniel J. Cua
  • Research scientist, Merck & Co., Inc., MRL, Palo Alto, USA, USA,
Research focus
  • Immunology
  • 1 Author merit


PhD, University of Southern California, USA, 1992

Current position

Senior Principal Scientist, Immunology Discovery, Merck Research Labs, USA


  1. https://scholar.google.com/citations?user=BIm2gvwAAAAJ&hl=en&oi=ao
1 Protocol published
Induction and Analysis of Anti-CD40-induced Colitis in Mice
Authors:  Barbara Joyce-Shaikh, Daniel J. Cua and David Bauché, date: 02/05/2019, view: 6390, Q&A: 0
Colon inflammation or colitis affects more than 1 million people worldwide. Several pre-clinical models, including chemical-induced (i.e., DSS, TNBS) or pathogen-induced (i.e., Citrobacter rodentium) have been used to ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.